Literature DB >> 36001245

Effect of low-level light therapy before radiotherapy in oral squamous cell carcinoma: An in vitro study.

Angeliny Tamiarana Lima Tabosa1,2, Marcela Gonçalves Souza1,2, Sabrina Ferreira de Jesus1,2, Danielle Ferreira Rocha1,2, Lorena Dos Reis Pereira Queiroz1,2, Eloá Mangabeira Santos1,2, Victor Hugo Dantas Guimarães1,2, Luciano Alves de Araújo Andrade3, Sérgio Henrique Santos4,2, Alfredo Maurício Batista de Paula1,2, Paulo Eduardo Narcizo de Souza5, Lucyana Conceição Farias1,2, André Luiz Sena Guimarães6,7,8.   

Abstract

Radiation therapy for head and neck squamous cell carcinoma (HNSCC) is associated with several complications. Although photobiomodulation (PBM) has radioprotective effects in normal tissue, it could also enhance the growth of neoplastic cells. Thus, the present study aimed to investigate the cellular response of oral squamous cell carcinoma with pre-exposure to low-level phototherapy before radiotherapy. SCC9, Cal-27, A431, and HaCaT cell lines were subjected to low-level light therapy and radiotherapy. The cells were treated with a single energy density (300 J/cm2) of a light-emitting diode (660 nm) prior to ionizing radiation at different doses (0, 2, 4, and 6 Gy). After 24 h, wound scratch, proliferation, clonogenic cell survival, cell death, and reactive oxygen species (ROS) analyses were performed to evaluate cell response. The cell lines pre-exposed to PBM at the analyzed dosage were radiosensitive. The treatment significantly reduced cell proliferation and clonogenic cell survival. Migration and cell death assays also revealed positive results, with the treatment group showing lower rate of migration and higher cell death than did the control group. Moreover, PBM effectively increased the intracellular levels of ROS. PBM at 300 J/cm2 is a promising radiosensitizing modality to reduce the radiation dose and avoid the intolerable side effects of radiotherapy for HNSCC, thus increasing the probability of successful treatment. However, further studies are needed to support and confirm the results.
© 2022. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

Entities:  

Keywords:  Head and neck cancer; Ionizing radiation; LED; Low-level light therapy; Photobiomodulation; Radiosensitization

Year:  2022        PMID: 36001245     DOI: 10.1007/s10103-022-03632-x

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   2.555


  40 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells.

Authors:  Khalid M AlGhamdi; Ashok Kumar; Noura A Moussa
Journal:  Lasers Med Sci       Date:  2011-01-28       Impact factor: 3.161

3.  Genetic progression model for head and neck cancer: implications for field cancerization.

Authors:  J Califano; P van der Riet; W Westra; H Nawroz; G Clayman; S Piantadosi; R Corio; D Lee; B Greenberg; W Koch; D Sidransky
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

4.  Photobiomodulation is associated with a decrease in cell viability and migration in oral squamous cell carcinoma.

Authors:  Tatiana Dias Schalch; Maria Helena Fernandes; Maria Fernanda Setúbal Destro Rodrigues; Douglas Magno Guimarães; Fabio Daumas Nunes; João Costa Rodrigues; Mônica Pereira Garcia; Raquel Agnelli Mesquita Ferrari; Sandra Kalil Bussadori; Kristianne Porta Santos Fernandes
Journal:  Lasers Med Sci       Date:  2018-09-19       Impact factor: 3.161

5.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 6.  TNM staging of cancers of the head and neck: striving for uniformity among diversity.

Authors:  Snehal G Patel; Jatin P Shah
Journal:  CA Cancer J Clin       Date:  2005 Jul-Aug       Impact factor: 508.702

Review 7.  Head and neck squamous cell carcinoma.

Authors:  Daniel E Johnson; Barbara Burtness; C René Leemans; Vivian Wai Yan Lui; Julie E Bauman; Jennifer R Grandis
Journal:  Nat Rev Dis Primers       Date:  2020-11-26       Impact factor: 52.329

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.

Authors:  Talita Antunes Guimarães; Lucyana Conceição Farias; Eliane Sobrinho Santos; Carlos Alberto de Carvalho Fraga; Lissur Azevedo Orsini; Leandro de Freitas Teles; John David Feltenberger; Sabrin Ferreira de Jesus; Marcela Gonçalves de Souza; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; Ricardo Santiago Gomez; André Luiz Sena Guimarães
Journal:  Oncotarget       Date:  2016-08-23

10.  Head and neck cancer: Current challenges and future perspectives.

Authors:  Gh Rasool Bhat; Rosalie G Hyole; Jiong Li
Journal:  Adv Cancer Res       Date:  2021-06-16       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.